
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/base_style-CPPDhfna.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-BepKMsUl.js"></script>

  <link rel="stylesheet" href="/static/assets/article_style-DUfI1jZp.css" />
<link rel="stylesheet" href="/static/assets/style-BOrsu84o.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-D3wJHomh.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="CFBE24C8930B13630024C800217619D3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontpharmacol">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12259682/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Pharmacology">
<meta name="citation_title" content="A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide">
<meta name="citation_author" content="Mengmeng Huang">
<meta name="citation_author_institution" content="Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China">
<meta name="citation_author_institution" content="Department of Pharmacy, Lu &#x27;an Hospital of Anhui Medical University, Lu &#x27;an, Anhui, China">
<meta name="citation_author" content="Guangwei Liu">
<meta name="citation_author_institution" content="Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China">
<meta name="citation_author" content="Chuanzhou Zhang">
<meta name="citation_author_institution" content="Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China">
<meta name="citation_author" content="Ying Wang">
<meta name="citation_author_institution" content="Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China">
<meta name="citation_author_institution" content="Department of Pharmacy, Mengyin County People’s Hospital, Linyi, Shandong, China">
<meta name="citation_author" content="Shengfen Liu">
<meta name="citation_author_institution" content="Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China">
<meta name="citation_author_institution" content="Department of Pharmacy, The Third People’s Hospital of Huangdao District, Qingdao, Shandong, China">
<meta name="citation_author" content="Jun Zhao">
<meta name="citation_author_institution" content="Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China">
<meta name="citation_publication_date" content="2025 Jul 1">
<meta name="citation_volume" content="16">
<meta name="citation_firstpage" content="1608657">
<meta name="citation_doi" content="10.3389/fphar.2025.1608657">
<meta name="citation_pmid" content="40667509">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12259682/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12259682/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12259682/pdf/fphar-16-1608657.pdf">
<meta name="description" content="With the increasing clinical use of tirzepatide, its safety profile has garnered significant attention. This article systematically reviews case reports of tirzepatide-associated adverse drug reactions (ADRs) to summarize their characteristics. We ...">
<meta name="og:title" content="A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="With the increasing clinical use of tirzepatide, its safety profile has garnered significant attention. This article systematically reviews case reports of tirzepatide-associated adverse drug reactions (ADRs) to summarize their characteristics. We ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12259682/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12259682">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fphar.2025.1608657"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fphar-16-1608657.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12259682%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12259682/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12259682/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12259682/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontpharmacol.gif" alt="Frontiers in Pharmacology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Pharmacology" title="Link to Frontiers in Pharmacology" shape="default" href="http://www.frontiersin.org/pharmacology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Pharmacol</button></div>. 2025 Jul 1;16:1608657. doi: <a href="https://doi.org/10.3389/fphar.2025.1608657" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fphar.2025.1608657</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Pharmacol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Pharmacol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Pharmacol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Pharmacol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Mengmeng Huang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Mengmeng Huang</span></h3>
<div class="p">
<sup>1</sup>
Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
</div>
<div class="p">
<sup>2</sup>
Department of Pharmacy, Lu 'an Hospital of Anhui Medical University, Lu 'an, Anhui, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mengmeng Huang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Guangwei Liu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Guangwei Liu</span></h3>
<div class="p">
<sup>3</sup>
Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guangwei Liu</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Chuanzhou Zhang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Chuanzhou Zhang</span></h3>
<div class="p">
<sup>1</sup>
Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chuanzhou Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ying Wang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ying Wang</span></h3>
<div class="p">
<sup>1</sup>
Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
</div>
<div class="p">
<sup>4</sup>
Department of Pharmacy, Mengyin County People’s Hospital, Linyi, Shandong, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Ying Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Shengfen Liu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Shengfen Liu</span></h3>
<div class="p">
<sup>1</sup>
Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
</div>
<div class="p">
<sup>5</sup>
Department of Pharmacy, The Third People’s Hospital of Huangdao District, Qingdao, Shandong, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shengfen Liu</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Jun Zhao</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Jun Zhao</span></h3>
<div class="p">
<sup>1</sup>
Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jun Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
</div>
<div id="aff2">
<sup>2</sup>
Department of Pharmacy, Lu 'an Hospital of Anhui Medical University, Lu 'an, Anhui, China
</div>
<div id="aff3">
<sup>3</sup>
Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
</div>
<div id="aff4">
<sup>4</sup>
Department of Pharmacy, Mengyin County People’s Hospital, Linyi, Shandong, China
</div>
<div id="aff5">
<sup>5</sup>
Department of Pharmacy, The Third People’s Hospital of Huangdao District, Qingdao, Shandong, China
</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>
<strong>Edited by:</strong>
<a href="https://loop.frontiersin.org/people/75206/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Eleonore Fröhlich</a>, Medical University of Graz, Austria</p></div>
<div class="fn" id="fn2">
<p>
<strong>Reviewed by:</strong>
<a href="https://loop.frontiersin.org/people/1117659/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Livan Delgado-Roche</a>, Laboratorios Liomont SA, Mexico</p>
<p>
<a href="https://loop.frontiersin.org/people/2140389/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Trang Thi Bich Le</a>, Ho Chi Minh City Medicine and Pharmacy University, Vietnam</p>
<p>
<a href="https://loop.frontiersin.org/people/2996486/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Hidehiro Someko</a>, Kyoto University, Japan</p>
</div>
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">*Correspondence: Jun Zhao, <span>zhaojun@qduhospital.cn</span>
</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 9; Accepted 2025 Jun 16; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 Huang, Liu, Zhang, Wang, Liu and Zhao.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12259682  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40667509/" class="usa-link">40667509</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>With the increasing clinical use of tirzepatide, its safety profile has garnered significant attention. This article systematically reviews case reports of tirzepatide-associated adverse drug reactions (ADRs) to summarize their characteristics.</p></section><section id="sec2"><h3 class="pmc_sec_title">Method</h3>
<p>We searched PubMed, Web of Science, ScienceDirect, Wiley Online, and Embase databases for case reports on tirzepatide adverse events using the keywords: “tirzepatide”, “adverse reaction”, “adverse event”, “side effect”, “safety”, “case report”, “induced”, “associated”, and “related”. Statistical analysis was performed on the identified cases.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>A total of 43 cases of tirzepatide ADR were identified from 37 articles. Among these patients (24 female, 19 male; mean age 50.23 ± 17.24 years), 19 involved concomitant medications affecting multiple systems. ADR was reported in each dosage of tirzepatide, with the most occurring at 2.5–5 mg (16 cases), and primarily occurred within 1–6 months of initiation. Regarding rechallenge, 15 patients discontinued tirzepatide, three continued use, and one reduced the dose. ADR involved seven gastrointestinal tract and endocrine systems, including liver and gallbladder, circulation, nerve, skin, and urinary. Notable manifestations included ketoacidosis, liver injury, hypotension, intestinal obstruction, and allergic reactions. Among them, ketoacidosis and common peroneal neuropathy causing foot sagging, acute appendicitis, lower limb venous thrombosis, gastric outlet obstruction, gastric emptying delay, and acute liver injury were not mentioned in the drug instructions. ADR correlation assessment was performed for 8 patients:4 cases of cardiovascular events and ketoacidosis were all evaluated as “probable” using the Naranjo scale, 3 cases of liver injury were assessed by RUCAM (2 case as “possible”, 1 cases as “probable”), 1 case did not specify the evaluation method, with the result being “highly probable”. All 43 patients underwent ADR correlation re-evaluation:32 cases (74.42%) were assessed as “probable”,11 cases (25.58%) were assessed as “possible”.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p>Tirzepatide-associated ADRs most commonly occur within the first 6 months of treatment, primarily affecting the digestive, endocrine, liver, and gallbladder systems. Enhanced monitoring of liver and kidney function is warranted, especially in patients concurrently taking other potentially hepatotoxic or nephrotoxic medications. Additionally, intensified therapeutic drug monitoring is recommended for patients with cardiovascular disease, those requiring weight-based dosing adjustments, and those experiencing rapid weight loss.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> ADR, case report, systematic analysis, tirzepatide, adverse drug reactions</p></section></section><section id="s1"><h2 class="pmc_sec_title">1 Introduction</h2>
<p>Tirzepatide is the first dual-target agonist that targets both the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide (GIP) receptors, resulting in significant improvements in glucose control and weight without increasing the risk of hypoglycemia (<a href="#B53" class="usa-link" aria-describedby="B53">Rosenstock et al., 2021</a>). Approved in the United States in May 2022 by the Food and Drug Administration (FDA) for glycemic control in adults with type 2 diabetes, tirzepatide received weight loss approval in November 2023. The FDA approved tirzepatide in December 2024 as the first drug to treat adults with moderate to severe obstructive sleep apnea (OSA), marking a significant milestone in OSA treatment (<a href="#B16" class="usa-link" aria-describedby="B16">FDA, 2024</a>). It is currently in Phase III clinical trials for the treatment of heart failure, obesity, and cardiovascular diseases associated with type 2 diabetes, along with Phase II trials for non-alcoholic steatohepatitis (<a href="#B60" class="usa-link" aria-describedby="B60">Syed, 2022</a>). As can be seen, tirzepatide has a substantial clinical application potential.</p>
<p>As tirzepatide is increasingly used in type 2 diabetes, obesity, OSA, and other fields, adverse effects such as injection site reactions and gastrointestinal symptoms, warrant increased attention (<a href="#B8" class="usa-link" aria-describedby="B8">Caruso et al., 2024</a>). There is currently no literature to assess its safety. Therefore, this study systematically reviewstirzepatide-related ADR case reports to analyzeoccurrence pattern, causes, severity, preventability, and outcomes, providing a foundation for safe and effective use.</p></section><section id="s2"><h2 class="pmc_sec_title">2 Methods</h2>
<section id="s2-1"><h3 class="pmc_sec_title">2.1 Source and search strategy</h3>
<p>The search for the terms “tirzepatide”, “adverse reaction”, “adverse event”, “side effect”, “safety”, “case report”, “induced”, “associated”, and “related” was conducted in PubMed, Web of Science, ScienceDirect, Wiley Online, and Embase databases. The search time was from the inception of the library until March 2025. The search was performed using subject headings alongside free words. Two researchers independentlyscreened articles according to the inclusion and exclusion criteria. Differences were resolved through consensus or consultation with a third reviewer, with the literature being decided to be included as part of the discussion.</p></section><section id="s2-2"><h3 class="pmc_sec_title">2.2 Qualification criteria and research</h3>
<p>The inclusion criteria for this study were: (1) Publicly published clinical case reports (2) complete clinical data, such as patient information (gender, age), primary disease, ADR occurrence and outcome. Exclusion criteria included: (1) non-case reporting literature or non-English studies, such as reviews, experimental research, observational research, and other non-English studies; (2) incomplete literature that could not be analyzed; and (3) duplicate publications.</p></section><section id="s2-3"><h3 class="pmc_sec_title">2.3 Data extraction and quality assessment</h3>
<p>This study collected data on the year, country, age, gender, primary disease, dose during ADR occurrence, time to first onset, clinical manifestations, intervention measures, drug re-challenge, outcome and outcome time, combined medication use, and ADR correlation evaluation. The ADRs in the included cases were re-evaluated for causality using the Naranjo Adverse Drug Reaction Probability Scale. The Naranjo assessment method primarily summarizes the scores based on Naranjo’s ten detailed rules, dividing the total score results into four levels: “definite”,“probable”,“possible”,“doubtful”. Data was entered into Microsoft Excel worksheet for statistics.</p></section><section id="s2-4"><h3 class="pmc_sec_title">2.4 Statistical analysis</h3>
<p>Statistical analysis was performed using SPSS (version 29.0.1.0). Continuous variables were expressed as mean ± standard deviation, while categorical variables were expressed as frequency and percentage.</p></section></section><section id="s3"><h2 class="pmc_sec_title">3 Results</h2>
<section id="s3-1"><h3 class="pmc_sec_title">3.1 Search results and case characteristics</h3>
<p>According to the inclusion and exclusion criteria, 37 articles meeting the criteria were included (<a href="#B9" class="usa-link" aria-describedby="B9">Chan et al., 2025</a>; <a href="#B45" class="usa-link" aria-describedby="B45">Morgenthaler and Depietro, 2024</a>; <a href="#B40" class="usa-link" aria-describedby="B40">Mathew and Hannoodee, 2023</a>; <a href="#B50" class="usa-link" aria-describedby="B50">Rao and Nimako, 2023</a>; <a href="#B47" class="usa-link" aria-describedby="B47">Peicher et al., 2023</a>; <a href="#B3" class="usa-link" aria-describedby="B3">Bayless et al., 2024</a>; <a href="#B4" class="usa-link" aria-describedby="B4">Betchvaia et al., 2024</a>; <a href="#B39" class="usa-link" aria-describedby="B39">Mando et al., 2024</a>; <a href="#B22" class="usa-link" aria-describedby="B22">Gordon et al., 2023</a>; <a href="#B23" class="usa-link" aria-describedby="B23">Grennan et al., 2024</a>; <a href="#B21" class="usa-link" aria-describedby="B21">Gomez Casanovas et al., 2023</a>; <a href="#B64" class="usa-link" aria-describedby="B64">Weber et al., 2023</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Iskander et al., 2025</a>; <a href="#B14" class="usa-link" aria-describedby="B14">Fadel et al., 2024</a>; <a href="#B1" class="usa-link" aria-describedby="B1">Abdullah et al., 2024</a>; <a href="#B33" class="usa-link" aria-describedby="B33">Klein et al., 2024</a>; <a href="#B59" class="usa-link" aria-describedby="B59">Sohal et al., 2024</a>; <a href="#B18" class="usa-link" aria-describedby="B18">Fontana et al., 2024</a>; <a href="#B61" class="usa-link" aria-describedby="B61">Terrington et al., 2024</a>; <a href="#B27" class="usa-link" aria-describedby="B27">Iqbal et al., 2024</a>; <a href="#B37" class="usa-link" aria-describedby="B37">Louwagie et al., 2025</a>; <a href="#B5" class="usa-link" aria-describedby="B5">Bitar et al., 2024</a>; <a href="#B24" class="usa-link" aria-describedby="B24">Gurel et al., 2024</a>; <a href="#B42" class="usa-link" aria-describedby="B42">Mercer et al., 2023a</a>; <a href="#B31" class="usa-link" aria-describedby="B31">Karakus et al., 2024</a>; <a href="#B43" class="usa-link" aria-describedby="B43">Mercer et al., 2023b</a>; <a href="#B36" class="usa-link" aria-describedby="B36">Le et al., 2024</a>; <a href="#B25" class="usa-link" aria-describedby="B25">He et al., 2023</a>; <a href="#B44" class="usa-link" aria-describedby="B44">Mizumoto, 2023</a>; <a href="#B62" class="usa-link" aria-describedby="B62">Tucker and Ritchie, 2024</a>; <a href="#B29" class="usa-link" aria-describedby="B29">Jamail et al., 2024</a>; <a href="#B6" class="usa-link" aria-describedby="B6">Bobbs and Howland, 2024</a>; <a href="#B52" class="usa-link" aria-describedby="B52">Rivera et al., 2023</a>; <a href="#B32" class="usa-link" aria-describedby="B32">Kido et al., 2024</a>; <a href="#B15" class="usa-link" aria-describedby="B15">Farooqi et al., 2024</a>; <a href="#B2" class="usa-link" aria-describedby="B2">Aleman et al., 2023</a>; <a href="#B17" class="usa-link" aria-describedby="B17">Fisher et al., 2025</a>), reporting 43 cases. <a href="#F1" class="usa-link">Figure 1</a> illustrates the literature screening process. The reported ADR cases originated most frequently from the United States (33/43), followed by Kuwait (6/43), the United Kingdom (1/43), Japan (1/43), the United Arab Emirates (1/43), and Nigeria (1/43). The 43 patients ranged in age from 17 to 77 years, averaging 50.23 ± 17.24 years. There were 24 female cases (mean age 42.96 ± 16.43 years) and 19 male cases (mean age 59.42 ± 13.45 years). Body mass index (BMI) data were available for 20 patients, averaging 33.02 ± 5.69 kg/m<sup>2</sup>. Detailed case characteristics are provided in <a href="#s13" class="usa-link">Supplementary Table S1</a>.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12259682_fphar-16-1608657-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09c1/12259682/3862e0a04bb1/fphar-16-1608657-g001.jpg" loading="lazy" alt="Flowchart detailing the process of selecting studies for review. Starting with 6,725 records identified, 4,882 duplicates, 4,873 ineligibles, and 9 non-English records were removed, leaving 1,843 for screening. 1,795 non-ADR-related records were then excluded. Forty-eight reports were sought, and seven were not retrieved. Forty-one assessed for eligibility resulted in four duplicates excluded. Finally, thirty-seven new studies were included in the review." height="657" width="800"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Document screening flow chart (PROSPERO).</p></figcaption></figure></section><section id="s3-2"><h3 class="pmc_sec_title">3.2 Purpose of medication and dosage</h3>
<p>Among the 43 patients, dosage information was not reported for 16 cases, and the primary disease was not documented in one case. <a href="#T1" class="usa-link">Table 1</a> contains information about the ADR for tirzepatide, including the dose and purpose.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Dosage and purpose of tirzepatide when ADR occurred.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="center" rowspan="1" colspan="1">Dose</th>
<th align="center" rowspan="1" colspan="1">T2DM, obesity</th>
<th align="center" rowspan="1" colspan="1">T2DM</th>
<th align="center" rowspan="1" colspan="1">Obesity</th>
<th align="center" rowspan="1" colspan="1">Overweight</th>
<th align="center" rowspan="1" colspan="1">Not mentioned</th>
<th align="center" rowspan="1" colspan="1">T1DM, obesity</th>
<th align="center" rowspan="1" colspan="1">Pre-diabetes</th>
<th align="left" rowspan="1" colspan="1">Total</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="center" rowspan="1" colspan="1">2.5 mg</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">5 mg</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">7.5 mg</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">10 mg</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">2</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">12 mg</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">12.5 mg</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">2</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">15 mg</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">Not mentioned</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">16</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">Total</td>
<td align="center" rowspan="1" colspan="1">9</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">16</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">43</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s3-3"><h3 class="pmc_sec_title">3.3 ADR occurrence time, outcome, and re-challenge</h3>
<p>Of the 43 patients, ten did not specify the duration of medication when the ADR occurred (including two cases occurred during the first use), two cases (intestinal obstruction and allergies) occurred within 30 min, six occurred within 1 week, five occurred within 4 weeks, 16 occurred between January and June, and four occurred between June and December.</p>
<p>41 patients improved or recovered after discontinuing the drug and receiving symptomatic treatment, one died, and one had a poor prognosis. Outcome timing: Thirty patients improved after treatment but did not clearly record whether the medication was stopped during treatment, seven improved after treatment, three improved after treatment, two did not improve after treatment, and one did not stop the medication (dose reduction of the combination drug).</p>
<p>21 patients did not specify the outcome time, 9 patients within 1 week, 11 patients within one to 4 weeks, and 2 patients within 6 weeks. Drug rechallenge situation: 25 patients did not mentioned whether they should continue using it, 15 patientsdiscontinued the durg (including one did not stop using it at first but had recurring symptoms since), 3 patients continued using it (with one reduced the dose).</p></section><section id="s3-4"><h3 class="pmc_sec_title">3.4 ADR involvement system and clinical manifestations</h3>
<p>ADRs in 43 patients affected seven organ systems, including the gastrointestinal tract, endocrine, hepatobiliary, and circulatory. Clinical manifestations included intestinal obstruction, ischemia, ketoacidosis, liver injury, hypotension, and allergies. <a href="#T2" class="usa-link">Table 2</a> details the information ofthe ADR involvement system and clinical manifestations.</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>ADR involvement system and clinical manifestations.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="center" rowspan="1" colspan="1">System</th>
<th align="center" rowspan="1" colspan="1">Number of cases (% of the proportion)</th>
<th align="center" rowspan="1" colspan="1">Main manifestations (number of examples)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="center" rowspan="1" colspan="1">Gastrointestinal tract</td>
<td align="center" rowspan="1" colspan="1">14 (32.56)</td>
<td align="left" rowspan="1" colspan="1">Intestinal obstruction (4) Pancreatitis (3) Intestinal ischemia (2) Acute appendicitis (1) Gastric outlet obstruction (1) Delayed gastric emptying (1) Pancreatic cancer (1) Gastric dilation gastric stones (1)</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">Endocrine</td>
<td align="center" rowspan="1" colspan="1">10 (23.26)</td>
<td align="left" rowspan="1" colspan="1">Hypoglycemia ketoacidosis (non-diabetic patients) (4) Norm-glycemia ketoacidosis (non-diabetic patients) (1) Norm-glycemia ketoacidosis (diabetic patients) (2) Ketoacidosis (non-diabetic patients) (2) Rapid weight loss-related thyrotoxicosis (1)</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">Liver and gallbladder</td>
<td align="center" rowspan="1" colspan="1">5 (11.63)</td>
<td align="left" rowspan="1" colspan="1">Acute liver failure (1) Acute liver injury, coagulation dysfunction (1) Liver injury (1) Liver injury, increased drug concentration (1) Jaundice (1)</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">Nerve</td>
<td align="center" rowspan="1" colspan="1">5 (11.63)</td>
<td align="left" rowspan="1" colspan="1">Peroneal neuropathy causes foot sagging (2) Migraine (1) Paranoid and hallucination (1) Ataxia, encephalopathy (1)</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">Cycle</td>
<td align="center" rowspan="1" colspan="1">4 (9.30)</td>
<td align="left" rowspan="1" colspan="1">Hypotension, tachycardia (2) Hypotension (1) Extension in the lower limb vein (1)</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">Skin</td>
<td align="center" rowspan="1" colspan="1">4 (9.30)</td>
<td align="left" rowspan="1" colspan="1">Allergies (Binophase allergic reaction) (1) Systemic allergies (1) Rash and pain in the injection site (1)<br>Pigmented Liver Planus (1)</td>
</tr>
<tr>
<td align="center" rowspan="1" colspan="1">Urination</td>
<td align="center" rowspan="1" colspan="1">1 (2.33)</td>
<td align="left" rowspan="1" colspan="1">Acute renal injury (1)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s3-5"><h3 class="pmc_sec_title">3.5 ADR correlation evaluation</h3>
<p>Of the 43 patients, ADR correlation assessment was performed for 8 patients using either the Naranjo or RUCAM methods. RUCAM is a standardized scoring system designed to evaluate the likelihood of a causal link between drug-induced liver injury (DILI) and the implicated drug. The score classifies ADR’s causal relationship as excluded, unlikely, possible, probable, or highly probable. The results showed that 4 cases of cardiovascular events and ketoacidosis were all evaluated as “probable” using the Naranjo scale, 3 cases of liver injury were assessed by RUCAM (2 case as “possible”, 1 cases as “probable”), 1 case did not specify the evaluation method, with the result being “highly probable”. The causal relationship of adverse reactions was re-evaluated in 43 patients: 32 cases (74.42%) were evaluated as “probable”, and 11 cases (25.58%) were evaluated as “possible”. The evaluation results of 6cases in the original literature were consistent with the re-evaluation results.1 case was evaluated as “highly probable” in the original literature and “probable” in the re-evaluation, 1 case was evaluated as “possible” in the original literature and “probable” in the re-evaluation. The detailed evaluation results are shown in <a href="#s13" class="usa-link">Supplementary Table S1</a>.</p></section></section><section id="s4"><h2 class="pmc_sec_title">4 Discussions</h2>
<p>Tirzepatide is the first dual-target agonist that acts on GLP-1 and GIP receptors, significantly improving glycemic control and weight without increasing the risk of hypoglycemia (<a href="#B53" class="usa-link" aria-describedby="B53">Rosenstock et al., 2021</a>). Current research indicates that in patients with type 2 diabetes, tirzepatide outperforms other GLP-1 receptor agonists, such as semaglutide, regarding glycosylated hemoglobin and weight control (<a href="#B19" class="usa-link" aria-describedby="B19">Frías et al., 2021</a>).</p>
<section id="s4-1"><h3 class="pmc_sec_title">4.1 ADR features</h3>
<p>In this study, the male-to-female ratio of patients was 1.26:1, with adverse drug reactions occurring in all age groups. Due to the small number of statistical cases, the relationship between gender, age, and tirzepatide ADR cannot be established. The patient’s original condition was diabetes, obesity, or both. Three overweight patients did not indicate whether they had weight-related comorbidities, so their medications were taken as prescribed. Antihypertensive drugs, fat-adjusting drugs, contraceptives, antidepressants, thyroid hormone supplements, antidiabetic drugs, anticoagulants, and other medications were prescribed to 19 of the 43 patients. Due to the patients’ complex medication situation, no correlation was found between ADR occurrence and the original disease or combination of medications. Of the 43 patients, nine did not mention whether the dose increase was performed as required, eight increased according to the recommended dose, nine were treated at 2.5 mg per week, and one (ADR is acute liver failure) clearly stated (<a href="#B61" class="usa-link" aria-describedby="B61">Terrington et al., 2024</a>) that the patient did not increase at 2.5 mg when increasing the dose. This variation could be related to the occurrence of ADR. The relationships between ADRs, dose size, and increased standardization remain unknown.</p></section><section id="s4-2"><h3 class="pmc_sec_title">4.2 ADR generation mechanism</h3>
<section id="s4-2-1"><h4 class="pmc_sec_title">4.2.1 Gastrointestinal ADR</h4>
<p>Appendicitis, intestinal obstruction, colon ischemia, delayed gastric emptying, gastric outlet obstruction, pancreatitis, and pancreatic cancer are examples of gastrointestinal adverse drug reactions. Tirzepatide decreases gastric motility by inhibiting gastrointestinal motility and increasing pyloric region contraction, potentility causing fecal stasis, appendix obstruction, increased intraluminal pressure, inflammation, bacterial overgrowth, infection, and appendiceal mucositis (<a href="#B9" class="usa-link" aria-describedby="B9">Chan et al., 2025</a>). The GLP-1R is expressed in normal pancreatic tissues. GLP-1RA directly increases pancreatic enzyme secretion through GLP-1R expressed by pancreatic acini cells. In some patients treated with GLP-1RA, the levels of circulating pancreatic enzymes increase, thereby having an important impact on the pancreas (<a href="#B12" class="usa-link" aria-describedby="B12">Drucker, 2024</a>). Naranjo evaluated one case of adverse reaction to pancreatic cancer as “possible”, but with a score of only 2. 90% of pancreatic cancers occur in exocrine regions, and their development may take several years. The impact of this drug category on the occurrence of pancreatic cancer is still unclear, and more clinical evidence is needed for support (<a href="#B4" class="usa-link" aria-describedby="B4">Betchvaia et al., 2024</a>).</p>
<p>The instructions for tirzepatide currently do not mention adverse events of intestinal obstruction; however, in September 2023, the FDA added a warning about intestinal obstruction to the label of tirzepatide (<a href="#B63" class="usa-link" aria-describedby="B63">U.S. Food and Drug Administration, 2023</a>), emphasizing the importance of raising awareness about the potential side effects and severity of tirzepatide, particularly for patients with a history of colon surgery, multiple abdominal surgeries, or intestinal obstruction. Colon ischemia may be associated with decreased oral intake caused by glucagon-like peptide-1 receptor agonists (GLP-1RAs), which can result in systemic hypotension and, ultimately, ischemic colitis. Patients with a history of colon ischemia attacks, peripheral vascular disease, congestive heart failure, or irritable bowel syndrome, for example, should drink plenty of water while taking GLP-1RA to lower their risk, assuming no contraindications (<a href="#B3" class="usa-link" aria-describedby="B3">Bayless et al., 2024</a>). In this study, a patient with tirzepatide was delayed due to delayed gastric emptying, resulting in gastrointestinal tract clearance during the procedure. In a retrospective study of patients who underwent esophageal gastroduodenoscopy (EGD), Nadeem et al. discovered that the risk of GLP-1RA and gastric contents retention was four times higher, as was the risk of EGD termination (<a href="#B46" class="usa-link" aria-describedby="B46">Nadeem et al., 2024</a>). Patients taking drugs containing the GLP-1RA component may experience slower intestine clearance during the perioperative period.</p></section><section id="s4-2-2"><h4 class="pmc_sec_title">4.2.2 ADR of the endocrine system</h4>
<p>Endocrine ADR is primarily ketoacidosis, which includes normal blood sugar acidosis, and it affects both diabetic and non-diabetic patients. Starvation ketoacidosis is a potential cause of diabetic ketoacidosis (DKA) in obese patients who restrict their daily calorie intake to less than 500 calories (<a href="#B7" class="usa-link" aria-describedby="B7">Cahill, 2006</a>). Mild ketosis typically begins after fasting for 12–14 h, but it can progress to ketoacidosis in severe nutritional deficiency, ketoacidosis, pregnancy, and other conditions that necessitate hospitalization (<a href="#B58" class="usa-link" aria-describedby="B58">Slade and Ashurst, 2020</a>). Second, it could be linked to insulin resistance and metabolic abnormal obesity (<a href="#B54" class="usa-link" aria-describedby="B54">Samocha-Bonet et al., 2014</a>), and insulin resistance may indicate relative insulin deficiency. Insulin withdrawal or dose reduction is important in inducing DKA during GLP-1RA treatment (<a href="#B66" class="usa-link" aria-describedby="B66">Yang et al., 2022</a>). Euglycemic diabetic ketoacidosis (EDKA) is a subtype of DKA. Patients exhibit DKA symptoms, but their blood sugar levels are less than 250 mg/dL (typically less than 100 mg/dL) (<a href="#B51" class="usa-link" aria-describedby="B51">Rawla et al., 2017</a>; <a href="#B48" class="usa-link" aria-describedby="B48">Plewa et al., 2025</a>). Among the 9 patients with ketoacidosis, 2 patients, although combined with SGLT2 inhibitors, had been taking the SGLT2 inhibitors as planned. The symptoms of ketoacidosis occurred respectively after the replacement of tirzepatideand the injection of tirzepatide. The adverse reaction symptoms showed a temporal association with tirzepatide administration. It was considered that ketoacidosis was caused by tirzepatide. In two previous studies, there was no ketoacidosis in 405 patients who took SGLT-2i and tirzepatide. More research was needed to determine the absolute risk of EDKA when using tirzepatide alone or with other hypoglycemic drugs (<a href="#B38" class="usa-link" aria-describedby="B38">Ludvik et al., 2021</a>; <a href="#B30" class="usa-link" aria-describedby="B30">Kadowaki et al., 2022</a>).</p></section><section id="s4-2-3"><h4 class="pmc_sec_title">4.2.3 ADR of liver and gallbladder system</h4>
<p>Jaundice and acute liver injury are examples of hepatobiliary adverse reactions. Tirzepatide is beneficial to the liver, resulting in a significant reduction in liver fat content (<a href="#B20" class="usa-link" aria-describedby="B20">Gastaldelli et al., 2022</a>). The specific impact mechanism is still unknown. However, in this study, the liver aminotransferase in four patients exceeded the normal upper limit by threefold, and two of these patients experienced fluctuations in aminotransferase levels during treatment. The author speculates that tirzepatide causes rapid fat mobilization and increased liver enzyme levels. Four out of five patients in a phase 2a study of a selective glucocorticoid receptor modulator for treating metabolic dysfunction-related fatty liver disease increased their liver enzyme levels by more than 250 IU/mL. It is speculated that changes in liver enzyme levels are linked to rapid liver delipidation (<a href="#B34" class="usa-link" aria-describedby="B34">Kowdley et al., 2021</a>).</p>
<p>In this study, two cases of liver damage occurred soon after the dose increase, one of which did not strictly adhere to the protocol of increasing the dose by 2.5 mg every 4 weeks. Rapid weight loss, acute dehydration, and malnutrition could have reduced functional liver reserves, resulting in tirzepatide-induced liver damage. The fluconazole used in the treatment may have impaired this patient’s liver function (<a href="#B61" class="usa-link" aria-describedby="B61">Terrington et al., 2024</a>). It is recommended that patients taking tirzepatide have their liver function closely monitored, particularly during dose changes and when combined with drugs that can cause liver damage.</p></section><section id="s4-2-4"><h4 class="pmc_sec_title">4.2.4 Nervous system ADR</h4>
<p>Foot drop, paranoia, hallucination, and migraine are examples of nervous system adverse reactions. Foot sagging caused by common peroneal neuropathy is more common in studies involving rapid weight loss (<a href="#B65" class="usa-link" aria-describedby="B65">Weyns et al., 2007</a>; <a href="#B56" class="usa-link" aria-describedby="B56">Şen et al., 2020</a>), and its mechanism may be linked to the loss of fat pads that protect common peroneal nerves (<a href="#B57" class="usa-link" aria-describedby="B57">Shields et al., 2021</a>). Previous research has shown that the risk of common peroneal neuropathy is higher in those who lose weight quickly within 5–11 months (<a href="#B65" class="usa-link" aria-describedby="B65">Weyns et al., 2007</a>; <a href="#B35" class="usa-link" aria-describedby="B35">Lale et al., 2020</a>), which is highly consistent with the reported cases (7–8 months after use). In a multicenter study including 69 patients with peroneal mononeuropathy at the fibular head level, weight loss was the fourth most common etiology (14.5%), following posture (23.2%), surgery (21.7%), and unknown causes (16%), but ranking higher than trauma (10.1%) and external compression (5.8%) (<a href="#B11" class="usa-link" aria-describedby="B11">Denys and Vrieze, 2023</a>). For patients using rapid weight-loss medications, slow down the weight loss rate through close monitoring and dose adjustment to reduce the risk of complications like common peroneal neuropathy and foot drop. One patient in this study had headache hallucinations and a history of anxiety and depression but only developed paranoia and visual hallucinations after increasing the dose of tirzepatide, and the symptoms resolved after discontinuing the medication. The World Health Organization’s (WHO) global suspicious ADR database and alert database revealed suicide ideation signals associated with semaglutide (<a href="#B55" class="usa-link" aria-describedby="B55">Schoretsanitis et al., 2024</a>), and the risk ratio of suicidal ideation to semaglutide, liraglutide, and tirzepatide increased significantly (<a href="#B41" class="usa-link" aria-describedby="B41">Mcintyre et al., 2025</a>). It suggests that tirzepatide has a high risk of causing nervous system adverse reactions and should be monitored closely.</p></section><section id="s4-2-5"><h4 class="pmc_sec_title">4.2.5 Circulatory system ADR</h4>
<p>The circulatory system’s ADR is hypotension, associated with or without tachycardia and venous thrombosis in the lower limbs. All three patients with blood pressure drops took GLP-1RA (semaglutide and duraglutide) but did not experience symptomatic hypotension. The experiments confirmed that the antihypertensive effect of 10 mg or 15 mg/week is greater than that of semaglutide 1 mg/week, and the antihypertensive effect of 5 mg, 10 mg, and 15 mg/week is dose-dependent (<a href="#B10" class="usa-link" aria-describedby="B10">Dahl et al., 2022</a>). The antihypertensive effect of tirzepatide may not be due to weight loss alone; a meta-analysis found that every 1 kg of weight loss reduced blood pressure by 1 mmHg (<a href="#B13" class="usa-link" aria-describedby="B13">Drug Interaction Results Between Tirzepatide and Sacubitril/Valsartan M C, 2023</a>). The blood pressure drop in one patient was consistent with this rule, but the drop in the other two cases far exceeded it (weight loss of 1 kg is approximately 2.9 mmHg and 10 mmHg). Tirzepatide’s mechanism for lowering blood pressure is multifactorial, and better monitoring of vital signs and capacity status is required.</p>
<p>Obesity and the risk of dehydration from decreased intake are common risk factors for venous thromboembolism (VTE) (<a href="#B49" class="usa-link" aria-describedby="B49">Prandoni, 2005</a>). The study found that participants who lost weight had a higher risk of VTE (<a href="#B26" class="usa-link" aria-describedby="B26">Horvei et al., 2016</a>). The study discovered that semaglutide increased the risk of VTE by 266% (relative risk was 3.66), raising concerns about its applicability among high-risk groups in VTE and reminding clinicians (<a href="#B67" class="usa-link" aria-describedby="B67">Yin et al., 2021</a>) to pay attention to the symptoms and signs of VTE that must be monitored during the treatment of GLP-1RA medications.</p></section><section id="s4-2-6"><h4 class="pmc_sec_title">4.2.6 Increased blood drug concentration causes ADR</h4>
<p>In this study, three patients experienced ADRs due to elevated drug concentrations from polypharmacy. The reason could be that the combined drug (e.g., levothyroxine sodium) failed to adjust the dose based on weight loss, resulting in thyroid toxicity; delayed gastric emptying and other causes increased drug absorption (e.g.,6-mercaptopurine), causing liver damage; competing with the drug (e.g., sodium valproate) with plasma albumin, increasing thefree drug concentrations, triggering a toxic reaction. When combined with dosage-adjusted drugs based on body weight and drugs with a high plasma protein binding rate, it is critical to monitor drug concentration in real-time and adjust the dose accordingly.</p></section></section><section id="s4-3"><h3 class="pmc_sec_title">4.3 Limitations</h3>
<p>This study is limited by its small sample size and restriction to case reports, which may have omitted relevant data. Additionally, tirzepatide’s short marketing period results in less relevant data, with most case reports being newly published. The analysis cited additional GLP-1RA-related research reports. The results may be biased; Further real-world studiesare required to demonstrate the relationship between drugs and ADR and underlying mechanisms.</p></section></section><section id="s5"><h2 class="pmc_sec_title">5 Conclusion</h2>
<p>Tirzepatide is a novel therapy forglycemic control in adults and long-term weight management in obese/overweight patients. Its excellent glycemic reduction, weight loss effect, and low ADR incidence make it popular among doctors and patients. However, in clinical applications, it is critical to monitor ADRs, particularly those that are not listed in the instructions, such as ketoacidosis, foot drop, and lower limb venous thrombosis. Some ADRs, such as acute liver function damage and severe systemic allergic reactions, are mentioned in the instructions, but their severity is high. The clinical application requires enhanced therapeutic drug monitoring for patients with liver/renal insufficiency, underlying cardiovascular diseases, combined drug use with flexible-dose adjustment, and rapid weight loss. In the future, long-term and real-world research are required to validate these findings.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by Natural Science Foundation of Shandong Province (No. ZR2021QH205) and Clinical Pharmacy Special Research and Academic Activity Project of Shandong Pharmaceutical Association (SDSYXH-39-2025-06).</p></section><section id="s6"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The original contributions presented in the study are included in the article/<a href="#s13" class="usa-link">Supplementary Material</a>, further inquiries can be directed to the corresponding author.</p></section><section id="s7"><h2 class="pmc_sec_title">Ethics statement</h2>
<p>Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements. Written informed consent to participate in this study was not required from the participants or the participants' legal guardians/next of kin in accordance with the national legislation and the institutional requirements.</p></section><section id="s8"><h2 class="pmc_sec_title">Author contributions</h2>
<p>MH: Writing – original draft. GL: Data curation, Writing – review and editing. CZ: Writing – review and editing, Data curation. YW: Writing – review and editing. SL: Writing – review and editing. JZ: Methodology, Writing – review and editing.</p></section><section id="s10"><h2 class="pmc_sec_title">Conflict of interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s11"><h2 class="pmc_sec_title">Generative AI statement</h2>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></section><section id="s12"><h2 class="pmc_sec_title">Publisher’s note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="s13"><h2 class="pmc_sec_title">Supplementary material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fphar.2025.1608657/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fphar.2025.1608657/full#supplementary-material</a>
</p>
<section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12259682/bin/Table1.docx" data-ga-action="click_feat_suppl" class="usa-link">Table1.docx</a><sup> (69.3KB, docx) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="B1">
<cite>
Abdullah I., El-Ghousain H., Alenezi M. (2024). Tirzepatide-related acute liver injury. Eur. J. Case Rep. Intern Med.
11 (9), 004813. 10.12890/2024_004813

</cite> [<a href="https://doi.org/10.12890/2024_004813" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11379107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39247248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Case%20Rep.%20Intern%20Med.&amp;title=Tirzepatide-related%20acute%20liver%20injury&amp;author=I.%20Abdullah&amp;author=H.%20El-Ghousain&amp;author=M.%20Alenezi&amp;volume=11&amp;issue=9&amp;publication_year=2024&amp;pages=004813&amp;pmid=39247248&amp;doi=10.12890/2024_004813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<cite>
Aleman E. A., Aleman Espino E., Aleman O. C., Monteagudo H., Frontela O. (2023). An incidental finding of a glucagon-like peptide 1 (GLP-1)-Induced acute kidney injury: a case report. Cureus
15 (9), e45261. 10.7759/cureus.45261

</cite> [<a href="https://doi.org/10.7759/cureus.45261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10503877/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37720126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cureus&amp;title=An%20incidental%20finding%20of%20a%20glucagon-like%20peptide%201%20(GLP-1)-Induced%20acute%20kidney%20injury:%20a%20case%20report&amp;author=E.%20A.%20Aleman&amp;author=E.%20Aleman%20Espino&amp;author=O.%20C.%20Aleman&amp;author=H.%20Monteagudo&amp;author=O.%20Frontela&amp;volume=15&amp;issue=9&amp;publication_year=2023&amp;pages=e45261&amp;pmid=37720126&amp;doi=10.7759/cureus.45261&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<cite>
Bayless D., Singh J., Park B. U., Sweetser S. (2024). Tirzepatide-associated colonic ischemia. ACG Case Rep. J.
11 (11), e01551. 10.14309/crj.0000000000001551

</cite> [<a href="https://doi.org/10.14309/crj.0000000000001551" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11540430/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39507503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACG%20Case%20Rep.%20J.&amp;title=Tirzepatide-associated%20colonic%20ischemia&amp;author=D.%20Bayless&amp;author=J.%20Singh&amp;author=B.%20U.%20Park&amp;author=S.%20Sweetser&amp;volume=11&amp;issue=11&amp;publication_year=2024&amp;pages=e01551&amp;pmid=39507503&amp;doi=10.14309/crj.0000000000001551&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<cite>
Betchvaia V., Betchvaia V., Daraselia D., Basheer S., Emina J., Mirza L. (2024). #1677365 A case of a 58-year-old man with type 2 DM who was diagnosed with pancreatic adenocarcinoma after treatment with tirzepatide. Endocr. Pract.
30 (5), S26. 10.1016/j.eprac.2024.03.168
</cite> [<a href="https://doi.org/10.1016/j.eprac.2024.03.168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocr.%20Pract.&amp;title=#1677365%20A%20case%20of%20a%2058-year-old%20man%20with%20type%202%20DM%20who%20was%20diagnosed%20with%20pancreatic%20adenocarcinoma%20after%20treatment%20with%20tirzepatide&amp;author=V.%20Betchvaia&amp;author=V.%20Betchvaia&amp;author=D.%20Daraselia&amp;author=S.%20Basheer&amp;author=J.%20Emina&amp;volume=30&amp;issue=5&amp;publication_year=2024&amp;pages=S26&amp;doi=10.1016/j.eprac.2024.03.168&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<cite>
Bitar Z., Abdelraouf H. M., Maig R. A., Maadarani O., Dashti H. (2024). Exploring hypoglycemic ketoacidosis in nondiabetic patients on tirzepatide: is starvation the culprit?
Am. J. Case Rep.
25, e946133. 10.12659/AJCR.946133

</cite> [<a href="https://doi.org/10.12659/AJCR.946133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11660008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39686534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Case%20Rep.&amp;title=Exploring%20hypoglycemic%20ketoacidosis%20in%20nondiabetic%20patients%20on%20tirzepatide:%20is%20starvation%20the%20culprit?&amp;author=Z.%20Bitar&amp;author=H.%20M.%20Abdelraouf&amp;author=R.%20A.%20Maig&amp;author=O.%20Maadarani&amp;author=H.%20Dashti&amp;volume=25&amp;publication_year=2024&amp;pages=e946133&amp;pmid=39686534&amp;doi=10.12659/AJCR.946133&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<cite>
Bobbs S., Howland J. (2024). A case of compounded tirzepatide-induced psychiatric adverse effects. Curr. Dev. Nutr.
8, 102316. 10.1016/j.cdnut.2024.102316
</cite> [<a href="https://doi.org/10.1016/j.cdnut.2024.102316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Dev.%20Nutr.&amp;title=A%20case%20of%20compounded%20tirzepatide-induced%20psychiatric%20adverse%20effects&amp;author=S.%20Bobbs&amp;author=J.%20Howland&amp;volume=8&amp;publication_year=2024&amp;pages=102316&amp;doi=10.1016/j.cdnut.2024.102316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<cite>
Cahill G. F., JR (2006). Fuel metabolism in starvation. Annu. Rev. Nutr.
26, 1–22. 10.1146/annurev.nutr.26.061505.111258

</cite> [<a href="https://doi.org/10.1146/annurev.nutr.26.061505.111258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16848698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Nutr.&amp;title=Fuel%20metabolism%20in%20starvation&amp;author=G.%20F.%20Cahill&amp;volume=26&amp;publication_year=2006&amp;pages=1-22&amp;pmid=16848698&amp;doi=10.1146/annurev.nutr.26.061505.111258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<cite>
Caruso I., Di Gioia L., Di Molfetta S., Caporusso M., Cignarelli A., Sorice G. P., et al.  (2024). The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database. J. Endocrinol. Invest.
47 (11), 2671–2678. 10.1007/s40618-024-02441-z

</cite> [<a href="https://doi.org/10.1007/s40618-024-02441-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11473560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39141075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Endocrinol.%20Invest.&amp;title=The%20real-world%20safety%20profile%20of%20tirzepatide:%20pharmacovigilance%20analysis%20of%20the%20FDA%20adverse%20event%20reporting%20system%20(FAERS)%20database&amp;author=I.%20Caruso&amp;author=L.%20Di%20Gioia&amp;author=S.%20Di%20Molfetta&amp;author=M.%20Caporusso&amp;author=A.%20Cignarelli&amp;volume=47&amp;issue=11&amp;publication_year=2024&amp;pages=2671-2678&amp;pmid=39141075&amp;doi=10.1007/s40618-024-02441-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<cite>
Chan G., Ansar M., Klein M. (2025). Appendicitis after initiation of tirzepatide. Diabetes Metab. Syndr. Obes.
18, 261–265. 10.2147/DMSO.S496739

</cite> [<a href="https://doi.org/10.2147/DMSO.S496739" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11791653/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39906694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Metab.%20Syndr.%20Obes.&amp;title=Appendicitis%20after%20initiation%20of%20tirzepatide&amp;author=G.%20Chan&amp;author=M.%20Ansar&amp;author=M.%20Klein&amp;volume=18&amp;publication_year=2025&amp;pages=261-265&amp;pmid=39906694&amp;doi=10.2147/DMSO.S496739&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<cite>
Dahl D., Onishi Y., Norwood P., Huh R., Bray R., Patel H., et al.  (2022). Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial. Jama
327 (6), 534–545. 10.1001/jama.2022.0078

</cite> [<a href="https://doi.org/10.1001/jama.2022.0078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8826179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35133415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jama&amp;title=Effect%20of%20subcutaneous%20tirzepatide%20vs%20placebo%20added%20to%20titrated%20insulin%20glargine%20on%20glycemic%20control%20in%20patients%20with%20type%202%20diabetes:%20the%20SURPASS-5%20randomized%20clinical%20trial&amp;author=D.%20Dahl&amp;author=Y.%20Onishi&amp;author=P.%20Norwood&amp;author=R.%20Huh&amp;author=R.%20Bray&amp;volume=327&amp;issue=6&amp;publication_year=2022&amp;pages=534-545&amp;pmid=35133415&amp;doi=10.1001/jama.2022.0078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<cite>
Denys C., Vrieze E. (2023). “Slimmer's paralysis”: peroneal neuropathy in anorexia nervosa. Tijdschr Psychiatr. 65 (9), 580–583.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/37947470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tijdschr%20Psychiatr&amp;title=%E2%80%9CSlimmer's%20paralysis%E2%80%9D:%20peroneal%20neuropathy%20in%20anorexia%20nervosa&amp;author=C.%20Denys&amp;author=E.%20Vrieze&amp;volume=65&amp;issue=9&amp;publication_year=2023&amp;pages=580-583&amp;pmid=37947470&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<cite>
Drucker D. J. (2024). Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity. Diabetes Care
47 (11), 1873–1888. 10.2337/dci24-0003

</cite> [<a href="https://doi.org/10.2337/dci24-0003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38843460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Efficacy%20and%20safety%20of%20GLP-1%20medicines%20for%20type%202%20diabetes%20and%20obesity&amp;author=D.%20J.%20Drucker&amp;volume=47&amp;issue=11&amp;publication_year=2024&amp;pages=1873-1888&amp;pmid=38843460&amp;doi=10.2337/dci24-0003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<cite>
Drug Interactions (2023). Drug interaction results between tirzepatide and sacubitril/valsatan M C, Spironolaction, empaglilozin, or dapagliflozin. in micromedex: drug interaction (columbia basin college lairery ed.). Available online at: <a href="http://www.Micromedexsolutions.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.Micromedexsolutions.com</a> [Accessed March 10, 2025].
</cite> [<a href="https://scholar.google.com/scholar_lookup?Drug%20Interactions%20(2023).%20Drug%20interaction%20results%20between%20tirzepatide%20and%20sacubitril/valsatan%20M%20C,%20Spironolaction,%20empaglilozin,%20or%20dapagliflozin.%20in%20micromedex:%20drug%20interaction%20(columbia%20basin%20college%20lairery%20ed.).%20Available%20online%20at:%20http://www.Micromedexsolutions.com%20%5BAccessed%20March%2010,%202025%5D." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<cite>
Fadel K., Lee M., Cricco-Lizza E., Smith E., Sahyoun L., Scherl E., et al.  (2024). S5010 A challenging case of gastric bezoar in a patient on tirzepatide. Official J. Am. Coll. Gastroenterology
119 (10S), S3152–S3153. 10.14309/01.ajg.0001049408.79846.f0
</cite> [<a href="https://doi.org/10.14309/01.ajg.0001049408.79846.f0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Official%20J.%20Am.%20Coll.%20Gastroenterology&amp;title=S5010%20A%20challenging%20case%20of%20gastric%20bezoar%20in%20a%20patient%20on%20tirzepatide&amp;author=K.%20Fadel&amp;author=M.%20Lee&amp;author=E.%20Cricco-Lizza&amp;author=E.%20Smith&amp;author=L.%20Sahyoun&amp;volume=119&amp;issue=10S&amp;publication_year=2024&amp;pages=S3152-S3153&amp;doi=10.14309/01.ajg.0001049408.79846.f0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<cite>
Farooqi M. F., Mehmood M. A., Khan M., Salman H. M., Agha A. (2024). Extensive deep vein thrombosis in a young man taking tirzepatide for weight loss. AACE Clin. Case Rep.
10 (6), 261–263. 10.1016/j.aace.2024.08.011

</cite> [<a href="https://doi.org/10.1016/j.aace.2024.08.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11680757/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39734498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AACE%20Clin.%20Case%20Rep.&amp;title=Extensive%20deep%20vein%20thrombosis%20in%20a%20young%20man%20taking%20tirzepatide%20for%20weight%20loss&amp;author=M.%20F.%20Farooqi&amp;author=M.%20A.%20Mehmood&amp;author=M.%20Khan&amp;author=H.%20M.%20Salman&amp;author=A.%20Agha&amp;volume=10&amp;issue=6&amp;publication_year=2024&amp;pages=261-263&amp;pmid=39734498&amp;doi=10.1016/j.aace.2024.08.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<cite>
Fisher C. M., Wilberg J. M., Rivera S. T., Krauland K. J., Edens C. (2025). Tirzepatide-induced Lichen planus pigmentosus. JAAD Case Rep.
59, 169–171. 10.1016/j.jdcr.2025.02.018
</cite> [<a href="https://doi.org/10.1016/j.jdcr.2025.02.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAAD%20Case%20Rep.&amp;title=Tirzepatide-induced%20Lichen%20planus%20pigmentosus&amp;author=C.%20M.%20Fisher&amp;author=J.%20M.%20Wilberg&amp;author=S.%20T.%20Rivera&amp;author=K.%20J.%20Krauland&amp;author=C.%20Edens&amp;volume=59&amp;publication_year=2025&amp;pages=169-171&amp;doi=10.1016/j.jdcr.2025.02.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<cite>
Fontana R. J., Choi E. K., Kaganove J., Dodson A. (2024). First report of tirzepatide hepatotoxicity with jaundice. Clin. Gastroenterol. Hepatol.
22 (12), 2538–2539. 10.1016/j.cgh.2024.06.025

</cite> [<a href="https://doi.org/10.1016/j.cgh.2024.06.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38964597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Gastroenterol.%20Hepatol.&amp;title=First%20report%20of%20tirzepatide%20hepatotoxicity%20with%20jaundice&amp;author=R.%20J.%20Fontana&amp;author=E.%20K.%20Choi&amp;author=J.%20Kaganove&amp;author=A.%20Dodson&amp;volume=22&amp;issue=12&amp;publication_year=2024&amp;pages=2538-2539&amp;pmid=38964597&amp;doi=10.1016/j.cgh.2024.06.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<cite>
Frías J. P., Davies M. J., Rosenstock J., Pérez Manghi F. C., Fernández Landó L., Bergman B. K., et al.  (2021). Tirzepatide <em>versus</em> semaglutide once weekly in patients with type 2 diabetes. N. Engl. J. Med.
385 (6), 503–515. 10.1056/NEJMoa2107519

</cite> [<a href="https://doi.org/10.1056/NEJMoa2107519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34170647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Tirzepatide%20versus%20semaglutide%20once%20weekly%20in%20patients%20with%20type%202%20diabetes&amp;author=J.%20P.%20Fr%C3%ADas&amp;author=M.%20J.%20Davies&amp;author=J.%20Rosenstock&amp;author=F.%20C.%20P%C3%A9rez%20Manghi&amp;author=L.%20Fern%C3%A1ndez%20Land%C3%B3&amp;volume=385&amp;issue=6&amp;publication_year=2021&amp;pages=503-515&amp;pmid=34170647&amp;doi=10.1056/NEJMoa2107519&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<cite>
Gastaldelli A., Cusi K., Fernández Landó L., Bray R., Brouwers B., Rodríguez Á. (2022). Effect of tirzepatide <em>versus</em> insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. Lancet Diabetes Endocrinol.
10 (6), 393–406. 10.1016/S2213-8587(22)00070-5

</cite> [<a href="https://doi.org/10.1016/S2213-8587(22)00070-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35468325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20Endocrinol.&amp;title=Effect%20of%20tirzepatide%20versus%20insulin%20degludec%20on%20liver%20fat%20content%20and%20abdominal%20adipose%20tissue%20in%20people%20with%20type%202%20diabetes%20(SURPASS-3%20MRI):%20a%20substudy%20of%20the%20randomised,%20open-label,%20parallel-group,%20phase%203%20SURPASS-3%20trial&amp;author=A.%20Gastaldelli&amp;author=K.%20Cusi&amp;author=L.%20Fern%C3%A1ndez%20Land%C3%B3&amp;author=R.%20Bray&amp;author=B.%20Brouwers&amp;volume=10&amp;issue=6&amp;publication_year=2022&amp;pages=393-406&amp;pmid=35468325&amp;doi=10.1016/S2213-8587(22)00070-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<cite>
Gomez Casanovas J., Bartl M., Blesset A., Lowery J., Parraga A. S. (2023). Abstract #1402779: a case of possible tirzepatide-induced pancreatitis. Endocr. Pract.
29 (5), S13. 10.1016/j.eprac.2023.03.034
</cite> [<a href="https://doi.org/10.1016/j.eprac.2023.03.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocr.%20Pract.&amp;title=Abstract%20#1402779:%20a%20case%20of%20possible%20tirzepatide-induced%20pancreatitis&amp;author=J.%20Gomez%20Casanovas&amp;author=M.%20Bartl&amp;author=A.%20Blesset&amp;author=J.%20Lowery&amp;author=A.%20S.%20Parraga&amp;volume=29&amp;issue=5&amp;publication_year=2023&amp;pages=S13&amp;doi=10.1016/j.eprac.2023.03.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<cite>
Gordon A., Dixit K., Shachi T. A. L., Salonia J., Seltzer E. (2023). A rare case of a large bowel obstruction due to tirzepatide. CHEST
164 (4), A2334–A2335. 10.1016/j.chest.2023.07.1569
</cite> [<a href="https://doi.org/10.1016/j.chest.2023.07.1569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CHEST&amp;title=A%20rare%20case%20of%20a%20large%20bowel%20obstruction%20due%20to%20tirzepatide&amp;author=A.%20Gordon&amp;author=K.%20Dixit&amp;author=T.%20A.%20L.%20Shachi&amp;author=J.%20Salonia&amp;author=E.%20Seltzer&amp;volume=164&amp;issue=4&amp;publication_year=2023&amp;pages=A2334-A2335&amp;doi=10.1016/j.chest.2023.07.1569&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<cite>
Grennan K., Grennan K., Meneley A., Shuman M., Borg C., Janitz T., et al.  (2024). #1698670 A case of fatal fulminant necrotizing pancreatitis in a patient with recent tirzepatide initiation. Endocr. Pract.
30 (5), S68. 10.1016/j.eprac.2024.03.258
</cite> [<a href="https://doi.org/10.1016/j.eprac.2024.03.258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocr.%20Pract.&amp;title=#1698670%20A%20case%20of%20fatal%20fulminant%20necrotizing%20pancreatitis%20in%20a%20patient%20with%20recent%20tirzepatide%20initiation&amp;author=K.%20Grennan&amp;author=K.%20Grennan&amp;author=A.%20Meneley&amp;author=M.%20Shuman&amp;author=C.%20Borg&amp;volume=30&amp;issue=5&amp;publication_year=2024&amp;pages=S68&amp;doi=10.1016/j.eprac.2024.03.258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<cite>
Gurel K., Mathew S., Zeidan M., Al Barznji S., Alkhankan F. (2024). 6660 euglycemic DKA induced by SGLT-2 inhibitor following administration ofTirzepatide. J. Endocr. Soc.
8, A401. 10.1210/jendso/bvae163.765
</cite> [<a href="https://doi.org/10.1210/jendso/bvae163.765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Endocr.%20Soc.&amp;title=6660%20euglycemic%20DKA%20induced%20by%20SGLT-2%20inhibitor%20following%20administration%20ofTirzepatide&amp;author=K.%20Gurel&amp;author=S.%20Mathew&amp;author=M.%20Zeidan&amp;author=S.%20Al%20Barznji&amp;author=F.%20Alkhankan&amp;volume=8&amp;publication_year=2024&amp;pages=A401&amp;doi=10.1210/jendso/bvae163.765&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<cite>
He Z., Tabe A. N., Rana S., King K. (2023). Tirzepatide-induced biphasic anaphylactic reaction: a case report. Cureus
15 (12), e50112. 10.7759/cureus.50112

</cite> [<a href="https://doi.org/10.7759/cureus.50112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10771104/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38186543/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cureus&amp;title=Tirzepatide-induced%20biphasic%20anaphylactic%20reaction:%20a%20case%20report&amp;author=Z.%20He&amp;author=A.%20N.%20Tabe&amp;author=S.%20Rana&amp;author=K.%20King&amp;volume=15&amp;issue=12&amp;publication_year=2023&amp;pages=e50112&amp;pmid=38186543&amp;doi=10.7759/cureus.50112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<cite>
Horvei L. D., Brækkan S. K., Hansen J.-B. (2016). Weight change and risk of venous thromboembolism: the tromsø study. PLOS ONE
11 (12), e0168878. 10.1371/journal.pone.0168878

</cite> [<a href="https://doi.org/10.1371/journal.pone.0168878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5173365/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27997594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLOS%20ONE&amp;title=Weight%20change%20and%20risk%20of%20venous%20thromboembolism:%20the%20troms%C3%B8%20study&amp;author=L.%20D.%20Horvei&amp;author=S.%20K.%20Br%C3%A6kkan&amp;author=J.-B.%20Hansen&amp;volume=11&amp;issue=12&amp;publication_year=2016&amp;pages=e0168878&amp;pmid=27997594&amp;doi=10.1371/journal.pone.0168878&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<cite>
Iqbal P. M. R., Maadarani O. S., Bitar Z. I. (2024). Tirzepatide-induced ketoacidosis in non-diabetic patients. Eur. J. Case Rep. Intern Med.
11 (4), 004357. 10.12890/2024_004357

</cite> [<a href="https://doi.org/10.12890/2024_004357" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10997393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38584893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Case%20Rep.%20Intern%20Med.&amp;title=Tirzepatide-induced%20ketoacidosis%20in%20non-diabetic%20patients&amp;author=P.%20M.%20R.%20Iqbal&amp;author=O.%20S.%20Maadarani&amp;author=Z.%20I.%20Bitar&amp;volume=11&amp;issue=4&amp;publication_year=2024&amp;pages=004357&amp;pmid=38584893&amp;doi=10.12890/2024_004357&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<cite>
Iskander M., Wadhwa M., Kim Y., Singh N., Pathak P. (2025). Acute functional gastric outlet obstruction associated with low-dose tirzepatide. Cureus
17 (1), e78090. 10.7759/cureus.78090

</cite> [<a href="https://doi.org/10.7759/cureus.78090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11867769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40026949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cureus&amp;title=Acute%20functional%20gastric%20outlet%20obstruction%20associated%20with%20low-dose%20tirzepatide&amp;author=M.%20Iskander&amp;author=M.%20Wadhwa&amp;author=Y.%20Kim&amp;author=N.%20Singh&amp;author=P.%20Pathak&amp;volume=17&amp;issue=1&amp;publication_year=2025&amp;pages=e78090&amp;pmid=40026949&amp;doi=10.7759/cureus.78090&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<cite>
Jamail J., Knowles R., Fuller L. (2024). Investigating GLP-1 Injections: Potential Mitochondrial Dysfunction in Non-Diabetic Patients Presenting with Migraines and Hypoglycemia: A Case Report. Integr Med (Encinitas). 23 (6), 21–5.
</cite> [<a href="/articles/PMC11737221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39830428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Integr%20Med%20(Encinitas)&amp;title=Investigating%20GLP-1%20Injections:%20Potential%20Mitochondrial%20Dysfunction%20in%20Non-Diabetic%20Patients%20Presenting%20with%20Migraines%20and%20Hypoglycemia:%20A%20Case%20Report&amp;author=J.%20Jamail&amp;author=R.%20Knowles&amp;author=L.%20Fuller&amp;volume=23&amp;issue=6&amp;publication_year=2024&amp;pages=21-5&amp;pmid=39830428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<cite>
Kadowaki T., Chin R., Ozeki A., Imaoka T., Ogawa Y. (2022). Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial. Lancet Diabetes Endocrinol.
10 (9), 634–644. 10.1016/S2213-8587(22)00187-5

</cite> [<a href="https://doi.org/10.1016/S2213-8587(22)00187-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35914542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20Endocrinol.&amp;title=Safety%20and%20efficacy%20of%20tirzepatide%20as%20an%20add-on%20to%20single%20oral%20antihyperglycaemic%20medication%20in%20patients%20with%20type%202%20diabetes%20in%20Japan%20(SURPASS%20J-combo):%20a%20multicentre,%20randomised,%20open-label,%20parallel-group,%20phase%203%20trial&amp;author=T.%20Kadowaki&amp;author=R.%20Chin&amp;author=A.%20Ozeki&amp;author=T.%20Imaoka&amp;author=Y.%20Ogawa&amp;volume=10&amp;issue=9&amp;publication_year=2022&amp;pages=634-644&amp;pmid=35914542&amp;doi=10.1016/S2213-8587(22)00187-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<cite>
Karakus K. E., Shah V. N., Akturk H. K. (2024). Tirzepatide-induced rapid weight loss-related thyrotoxicosis. JAMA Intern Med.
184 (10), 1246–1247. 10.1001/jamainternmed.2024.2919

</cite> [<a href="https://doi.org/10.1001/jamainternmed.2024.2919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39102259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Intern%20Med.&amp;title=Tirzepatide-induced%20rapid%20weight%20loss-related%20thyrotoxicosis&amp;author=K.%20E.%20Karakus&amp;author=V.%20N.%20Shah&amp;author=H.%20K.%20Akturk&amp;volume=184&amp;issue=10&amp;publication_year=2024&amp;pages=1246-1247&amp;pmid=39102259&amp;doi=10.1001/jamainternmed.2024.2919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<cite>
Kido K., Carey B., Caccamo M., Bianco C., Sokos G. (2024). Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy. J. Am. Pharm. Assoc. (2003)
64 (1), 169–173. 10.1016/j.japh.2023.09.011

</cite> [<a href="https://doi.org/10.1016/j.japh.2023.09.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37797920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Pharm.%20Assoc.%20(2003)&amp;title=Call%20to%20action%20for%20drug%20interactions%20between%20tirzepatide%20and%20heart%20failure%20guideline-directed%20medical%20therapy&amp;author=K.%20Kido&amp;author=B.%20Carey&amp;author=M.%20Caccamo&amp;author=C.%20Bianco&amp;author=G.%20Sokos&amp;volume=64&amp;issue=1&amp;publication_year=2024&amp;pages=169-173&amp;pmid=37797920&amp;doi=10.1016/j.japh.2023.09.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<cite>
Klein J. A., St-Pierre J., Choi D., Lopez J., Rubin D. T. (2024). Dramatic changes in thiopurine metabolite levels in a patient with inflammatory bowel disease treated with tirzepatide for weight loss. ACG Case Rep. J.
11 (11), e01544. 10.14309/crj.0000000000001544

</cite> [<a href="https://doi.org/10.14309/crj.0000000000001544" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11540429/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39507506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACG%20Case%20Rep.%20J.&amp;title=Dramatic%20changes%20in%20thiopurine%20metabolite%20levels%20in%20a%20patient%20with%20inflammatory%20bowel%20disease%20treated%20with%20tirzepatide%20for%20weight%20loss&amp;author=J.%20A.%20Klein&amp;author=J.%20St-Pierre&amp;author=D.%20Choi&amp;author=J.%20Lopez&amp;author=D.%20T.%20Rubin&amp;volume=11&amp;issue=11&amp;publication_year=2024&amp;pages=e01544&amp;pmid=39507506&amp;doi=10.14309/crj.0000000000001544&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<cite>
Kowdley K. V., Butler P., Cubberley S., Hand A. L., Jenders R. A., Kroon J., et al.  (2021). A selective GR modulator, induced a rapid and significant reduction in liver fat content in a randomized, placebocontrolled phase 2a study in patients with non-alcoholic steato-hepatitis. Hepatology
74 (6), 1412A. 10.1002/hep.32218
</cite> [<a href="https://doi.org/10.1002/hep.32218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=A%20selective%20GR%20modulator,%20induced%20a%20rapid%20and%20significant%20reduction%20in%20liver%20fat%20content%20in%20a%20randomized,%20placebocontrolled%20phase%202a%20study%20in%20patients%20with%20non-alcoholic%20steato-hepatitis&amp;author=K.%20V.%20Kowdley&amp;author=P.%20Butler&amp;author=S.%20Cubberley&amp;author=A.%20L.%20Hand&amp;author=R.%20A.%20Jenders&amp;volume=74&amp;issue=6&amp;publication_year=2021&amp;pages=1412A&amp;doi=10.1002/hep.32218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<cite>
Lale A., Kirkil C., Ozturk S., Yur M., Can O. F., Artaş G., et al.  (2020). The results of surgical decompression in the treatment of foot drop due to peroneal nerve entrapment after bariatric surgery. Surg. Obes. Relat. Dis.
16 (11), 1684–1691. 10.1016/j.soard.2020.06.054

</cite> [<a href="https://doi.org/10.1016/j.soard.2020.06.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32800521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Surg.%20Obes.%20Relat.%20Dis.&amp;title=The%20results%20of%20surgical%20decompression%20in%20the%20treatment%20of%20foot%20drop%20due%20to%20peroneal%20nerve%20entrapment%20after%20bariatric%20surgery&amp;author=A.%20Lale&amp;author=C.%20Kirkil&amp;author=S.%20Ozturk&amp;author=M.%20Yur&amp;author=O.%20F.%20Can&amp;volume=16&amp;issue=11&amp;publication_year=2020&amp;pages=1684-1691&amp;pmid=32800521&amp;doi=10.1016/j.soard.2020.06.054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<cite>
Le T. T. B., Minh L. H. N., Devi P., Islam N., Sachmechi I. (2024). A case report of systemic allergic reaction to the dual glucose-dependent insulinotropic Polypeptide/glucagon-like Peptide-1 receptor agonist tirzepatide. Cureus
16 (1), e51460. 10.7759/cureus.51460

</cite> [<a href="https://doi.org/10.7759/cureus.51460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10829695/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38298324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cureus&amp;title=A%20case%20report%20of%20systemic%20allergic%20reaction%20to%20the%20dual%20glucose-dependent%20insulinotropic%20Polypeptide/glucagon-like%20Peptide-1%20receptor%20agonist%20tirzepatide&amp;author=T.%20T.%20B.%20Le&amp;author=L.%20H.%20N.%20Minh&amp;author=P.%20Devi&amp;author=N.%20Islam&amp;author=I.%20Sachmechi&amp;volume=16&amp;issue=1&amp;publication_year=2024&amp;pages=e51460&amp;pmid=38298324&amp;doi=10.7759/cureus.51460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<cite>
Louwagie E. J., Diego J. N., Farooqi C. S., Kamal M. M. (2025). Euglycemic ketoacidosis following coadministration of an SGLT2 inhibitor and tirzepatide. JCEM Case Rep.
3 (3), luaf028. 10.1210/jcemcr/luaf028

</cite> [<a href="https://doi.org/10.1210/jcemcr/luaf028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11822847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39949871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCEM%20Case%20Rep.&amp;title=Euglycemic%20ketoacidosis%20following%20coadministration%20of%20an%20SGLT2%20inhibitor%20and%20tirzepatide&amp;author=E.%20J.%20Louwagie&amp;author=J.%20N.%20Diego&amp;author=C.%20S.%20Farooqi&amp;author=M.%20M.%20Kamal&amp;volume=3&amp;issue=3&amp;publication_year=2025&amp;pages=luaf028&amp;pmid=39949871&amp;doi=10.1210/jcemcr/luaf028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<cite>
Ludvik B., Giorgino F., Jódar E., Frias J. P., Fernández Landó L., Brown K., et al.  (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet
398 (10300), 583–598. 10.1016/S0140-6736(21)01443-4

</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)01443-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34370970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Once-weekly%20tirzepatide%20versus%20once-daily%20insulin%20degludec%20as%20add-on%20to%20metformin%20with%20or%20without%20SGLT2%20inhibitors%20in%20patients%20with%20type%202%20diabetes%20(SURPASS-3):%20a%20randomised,%20open-label,%20parallel-group,%20phase%203%20trial&amp;author=B.%20Ludvik&amp;author=F.%20Giorgino&amp;author=E.%20J%C3%B3dar&amp;author=J.%20P.%20Frias&amp;author=L.%20Fern%C3%A1ndez%20Land%C3%B3&amp;volume=398&amp;issue=10300&amp;publication_year=2021&amp;pages=583-598&amp;pmid=34370970&amp;doi=10.1016/S0140-6736(21)01443-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<cite>
Mando N., Thomson E., Fowler M., Short L., Gillen N. (2024). Acute pancreatitis caused by tirzepatide. Cureus
16 (12), e76007. 10.7759/cureus.76007

</cite> [<a href="https://doi.org/10.7759/cureus.76007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11743417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39834977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cureus&amp;title=Acute%20pancreatitis%20caused%20by%20tirzepatide&amp;author=N.%20Mando&amp;author=E.%20Thomson&amp;author=M.%20Fowler&amp;author=L.%20Short&amp;author=N.%20Gillen&amp;volume=16&amp;issue=12&amp;publication_year=2024&amp;pages=e76007&amp;pmid=39834977&amp;doi=10.7759/cureus.76007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<cite>
Mathew A., Hannoodee H. (2023). FRI643 tirzepatide associated partial small bowel obstruction: a case report. J. Endocr. Soc.
7 (Suppl_1). 10.1210/jendso/bvad114.862
</cite> [<a href="https://doi.org/10.1210/jendso/bvad114.862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Endocr.%20Soc.&amp;title=FRI643%20tirzepatide%20associated%20partial%20small%20bowel%20obstruction:%20a%20case%20report&amp;author=A.%20Mathew&amp;author=H.%20Hannoodee&amp;volume=7&amp;issue=Suppl_1&amp;publication_year=2023&amp;doi=10.1210/jendso/bvad114.862&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<cite>
Mcintyre R. S., Mansur R. B., Rosenblat J. D., Rhee T. G., Cao B., Teopiz K. M., et al.  (2025). Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: a replication study using reports to the world health organization pharmacovigilance database (VigiBase®). J. Affect Disord.
369, 922–927. 10.1016/j.jad.2024.10.062

</cite> [<a href="https://doi.org/10.1016/j.jad.2024.10.062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39433133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Affect%20Disord.&amp;title=Glucagon-like%20peptide-1%20receptor%20agonists%20(GLP-1%20RAs)%20and%20suicidality:%20a%20replication%20study%20using%20reports%20to%20the%20world%20health%20organization%20pharmacovigilance%20database%20(VigiBase%C2%AE)&amp;author=R.%20S.%20Mcintyre&amp;author=R.%20B.%20Mansur&amp;author=J.%20D.%20Rosenblat&amp;author=T.%20G.%20Rhee&amp;author=B.%20Cao&amp;volume=369&amp;publication_year=2025&amp;pages=922-927&amp;pmid=39433133&amp;doi=10.1016/j.jad.2024.10.062&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<cite>
Mercer J., Lipscomb J., Lipscomb J., Gao H., King K. (2023a). Tirzepatide-induced starvation ketoacidosis: a case report. Clin. Toxicol.
61, 14–15. 10.1080/15563650.2023.2233835
</cite> [<a href="https://doi.org/10.1080/15563650.2023.2233835" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37938168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Toxicol.&amp;title=Tirzepatide-induced%20starvation%20ketoacidosis:%20a%20case%20report&amp;author=J.%20Mercer&amp;author=J.%20Lipscomb&amp;author=J.%20Lipscomb&amp;author=H.%20Gao&amp;author=K.%20King&amp;volume=61&amp;publication_year=2023a&amp;pages=14-15&amp;pmid=37938168&amp;doi=10.1080/15563650.2023.2233835&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<cite>
Mercer J., Lipscomb J., Lipscomba J., Gao H. T., King K. (2023b). Tirzepatide-associated starvation ketoacidosis. Clin. Toxicol. (Phila)
61 (12), 1064–1065. 10.1080/15563650.2023.2277337

</cite> [<a href="https://doi.org/10.1080/15563650.2023.2277337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37938168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Toxicol.%20(Phila)&amp;title=Tirzepatide-associated%20starvation%20ketoacidosis&amp;author=J.%20Mercer&amp;author=J.%20Lipscomb&amp;author=J.%20Lipscomba&amp;author=H.%20T.%20Gao&amp;author=K.%20King&amp;volume=61&amp;issue=12&amp;publication_year=2023b&amp;pages=1064-1065&amp;pmid=37938168&amp;doi=10.1080/15563650.2023.2277337&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<cite>
Mizumoto J. (2023). Tirzepatide-induced injection site reaction. Cureus
15 (9), e45181. 10.7759/cureus.45181

</cite> [<a href="https://doi.org/10.7759/cureus.45181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10575762/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37842452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cureus&amp;title=Tirzepatide-induced%20injection%20site%20reaction&amp;author=J.%20Mizumoto&amp;volume=15&amp;issue=9&amp;publication_year=2023&amp;pages=e45181&amp;pmid=37842452&amp;doi=10.7759/cureus.45181&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<cite>
Morgenthaler L., DePietro R. (2024). Case Report: Small Bowel Obstruction After Starting Tirzepatide (Mounjaro). Am Fam Physician.
110 (6), 562.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/39700350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20Fam%20Physician.&amp;title=Case%20Report:%20Small%20Bowel%20Obstruction%20After%20Starting%20Tirzepatide%20(Mounjaro)&amp;author=L.%20Morgenthaler&amp;author=R.%20DePietro&amp;volume=110&amp;issue=6&amp;publication_year=2024&amp;pages=562&amp;pmid=39700350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<cite>
Nadeem D., Taye M., Still M. D., McShea S., Satterfield D., Dove J. T., et al.  (2024). Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and nondiabetic patients. Gastrointest. Endosc.
100 (4), 745–749. 10.1016/j.gie.2024.04.2900

</cite> [<a href="https://doi.org/10.1016/j.gie.2024.04.2900" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38692518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastrointest.%20Endosc.&amp;title=Effects%20of%20glucagon-like%20peptide-1%20receptor%20agonists%20on%20upper%20endoscopy%20in%20diabetic%20and%20nondiabetic%20patients&amp;author=D.%20Nadeem&amp;author=M.%20Taye&amp;author=M.%20D.%20Still&amp;author=S.%20McShea&amp;author=D.%20Satterfield&amp;volume=100&amp;issue=4&amp;publication_year=2024&amp;pages=745-749&amp;pmid=38692518&amp;doi=10.1016/j.gie.2024.04.2900&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<cite>
Peicher M., Montes O. B., Shekhar R. (2023). S3896 the risks of the new weight loss medications. Official J. Am. Coll. Gastroenterology | ACG
118 (10S), S2486. 10.14309/01.ajg.0000965224.61011.89
</cite> [<a href="https://doi.org/10.14309/01.ajg.0000965224.61011.89" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Official%20J.%20Am.%20Coll.%20Gastroenterology%20%7C%20ACG&amp;title=S3896%20the%20risks%20of%20the%20new%20weight%20loss%20medications&amp;author=M.%20Peicher&amp;author=O.%20B.%20Montes&amp;author=R.%20Shekhar&amp;volume=118&amp;issue=10S&amp;publication_year=2023&amp;pages=S2486&amp;doi=10.14309/01.ajg.0000965224.61011.89&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<cite>
Plewa M. C., Bryant M., King-Thiele R. (2025). Euglycemic Diabetic Ketoacidosis. Treasure Island (Florida): StatPearls.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/32119457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Plewa%20M.%20C.,%20Bryant%20M.,%20King-Thiele%20R.%20(2025).%20Euglycemic%20Diabetic%20Ketoacidosis.%20Treasure%20Island%20(Florida):%20StatPearls." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<cite>
Prandoni P. (2005). Acquired risk factors for venous thromboembolism in medical patients. Hematol. Am. Soc. Hematol. Educ. Program
2005, 458–461. 10.1182/asheducation-2005.1.458
</cite> [<a href="https://doi.org/10.1182/asheducation-2005.1.458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16304420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hematol.%20Am.%20Soc.%20Hematol.%20Educ.%20Program&amp;title=Acquired%20risk%20factors%20for%20venous%20thromboembolism%20in%20medical%20patients&amp;author=P.%20Prandoni&amp;volume=2005&amp;publication_year=2005&amp;pages=458-461&amp;pmid=16304420&amp;doi=10.1182/asheducation-2005.1.458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<cite>
Rao K., Nimako E. K. (2023). SAT680 mounjaro: a side effect. J. Endocr. Soc.
7 (Suppl_1). 10.1210/jendso/bvad114.128
</cite> [<a href="https://doi.org/10.1210/jendso/bvad114.128" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Endocr.%20Soc.&amp;title=SAT680%20mounjaro:%20a%20side%20effect&amp;author=K.%20Rao&amp;author=E.%20K.%20Nimako&amp;volume=7&amp;issue=Suppl_1&amp;publication_year=2023&amp;doi=10.1210/jendso/bvad114.128&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<cite>
Rawla P., Vellipuram A. R., Bandaru S. S., Pradeep Raj J. (2017). Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol. Diabetes Metab. Case Rep.
2017, 17-0081. 10.1530/EDM-17-0081
</cite> [<a href="https://doi.org/10.1530/EDM-17-0081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5592704/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28924481/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinol.%20Diabetes%20Metab.%20Case%20Rep.&amp;title=Euglycemic%20diabetic%20ketoacidosis:%20a%20diagnostic%20and%20therapeutic%20dilemma&amp;author=P.%20Rawla&amp;author=A.%20R.%20Vellipuram&amp;author=S.%20S.%20Bandaru&amp;author=J.%20Pradeep%20Raj&amp;volume=2017&amp;publication_year=2017&amp;pages=17-0081&amp;pmid=28924481&amp;doi=10.1530/EDM-17-0081&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<cite>
Rivera J. V., Marshall S., Chee-How E. (2023). Valproic Acid Toxicity After Initiation of Injectable Weight-Loss Drug: A Case Report. Journal of Medical Toxicology. 19 (2), 134–5. 10.1007/s13181-023-00930-w
</cite> [<a href="https://doi.org/10.1007/s13181-023-00930-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Medical%20Toxicology&amp;title=Valproic%20Acid%20Toxicity%20After%20Initiation%20of%20Injectable%20Weight-Loss%20Drug:%20A%20Case%20Report&amp;author=J.%20V.%20Rivera&amp;author=S.%20Marshall&amp;author=E.%20Chee-How&amp;volume=19&amp;issue=2&amp;publication_year=2023&amp;pages=134-5&amp;doi=10.1007/s13181-023-00930-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<cite>
Rosenstock J., Wysham C., Frias J. P., Kaneko S., Lee C. J., Fernández Landó L., et al.  (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet
398 (10295), 143–155. 10.1016/S0140-6736(21)01324-6

</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)01324-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34186022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Efficacy%20and%20safety%20of%20a%20novel%20dual%20GIP%20and%20GLP-1%20receptor%20agonist%20tirzepatide%20in%20patients%20with%20type%202%20diabetes%20(SURPASS-1):%20a%20double-blind,%20randomised,%20phase%203%20trial&amp;author=J.%20Rosenstock&amp;author=C.%20Wysham&amp;author=J.%20P.%20Frias&amp;author=S.%20Kaneko&amp;author=C.%20J.%20Lee&amp;volume=398&amp;issue=10295&amp;publication_year=2021&amp;pages=143-155&amp;pmid=34186022&amp;doi=10.1016/S0140-6736(21)01324-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<cite>
Samocha-Bonet D., Dixit V. D., Kahn C. R., Leibel R. L., Lin X., Nieuwdorp M., et al.  (2014). Metabolically healthy and unhealthy obese-the 2013 stock conference report. Obes. Rev.
15 (9), 697–708. 10.1111/obr.12199

</cite> [<a href="https://doi.org/10.1111/obr.12199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4519075/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25059108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Obes.%20Rev.&amp;title=Metabolically%20healthy%20and%20unhealthy%20obese-the%202013%20stock%20conference%20report&amp;author=D.%20Samocha-Bonet&amp;author=V.%20D.%20Dixit&amp;author=C.%20R.%20Kahn&amp;author=R.%20L.%20Leibel&amp;author=X.%20Lin&amp;volume=15&amp;issue=9&amp;publication_year=2014&amp;pages=697-708&amp;pmid=25059108&amp;doi=10.1111/obr.12199&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<cite>
Schoretsanitis G., Weiler S., Barbui C., Raschi E., Gastaldon C. (2024). Disproportionality analysis from world health organization data on semaglutide, liraglutide, and suicidality. JAMA Netw. Open
7 (8), e2423385. 10.1001/jamanetworkopen.2024.23385

</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2024.23385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11337067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39163046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw.%20Open&amp;title=Disproportionality%20analysis%20from%20world%20health%20organization%20data%20on%20semaglutide,%20liraglutide,%20and%20suicidality&amp;author=G.%20Schoretsanitis&amp;author=S.%20Weiler&amp;author=C.%20Barbui&amp;author=E.%20Raschi&amp;author=C.%20Gastaldon&amp;volume=7&amp;issue=8&amp;publication_year=2024&amp;pages=e2423385&amp;pmid=39163046&amp;doi=10.1001/jamanetworkopen.2024.23385&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<cite>
Şen O., Karaca F. C., Türkçapar A. (2020). Neurological complication after laparoscopic sleeve gastrectomy: foot drop. Obes. Surg.
30 (3), 957–960. 10.1007/s11695-019-04285-6

</cite> [<a href="https://doi.org/10.1007/s11695-019-04285-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31741213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Obes.%20Surg.&amp;title=Neurological%20complication%20after%20laparoscopic%20sleeve%20gastrectomy:%20foot%20drop&amp;author=O.%20%C5%9Een&amp;author=F.%20C.%20Karaca&amp;author=A.%20T%C3%BCrk%C3%A7apar&amp;volume=30&amp;issue=3&amp;publication_year=2020&amp;pages=957-960&amp;pmid=31741213&amp;doi=10.1007/s11695-019-04285-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<cite>
Shields L. B. E., Iyer V. G., Shields C. B., Zhang Y. P., Rao A. J. (2021). Varied presentation and importance of MR neurography of the common fibular nerve in slimmer's paralysis. Case Rep. Neurol.
13 (2), 555–564. 10.1159/000518377

</cite> [<a href="https://doi.org/10.1159/000518377" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8460930/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34720962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Case%20Rep.%20Neurol.&amp;title=Varied%20presentation%20and%20importance%20of%20MR%20neurography%20of%20the%20common%20fibular%20nerve%20in%20slimmer's%20paralysis&amp;author=L.%20B.%20E.%20Shields&amp;author=V.%20G.%20Iyer&amp;author=C.%20B.%20Shields&amp;author=Y.%20P.%20Zhang&amp;author=A.%20J.%20Rao&amp;volume=13&amp;issue=2&amp;publication_year=2021&amp;pages=555-564&amp;pmid=34720962&amp;doi=10.1159/000518377&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<cite>
Slade S., Ashurst J. (2020). Diet-induced ketoacidosis in a non-diabetic: a case report. Clin. Pract. Cases Emerg. Med.
4 (2), 259–262. 10.5811/cpcem.2020.2.44736

</cite> [<a href="https://doi.org/10.5811/cpcem.2020.2.44736" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7220017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32426688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Pract.%20Cases%20Emerg.%20Med.&amp;title=Diet-induced%20ketoacidosis%20in%20a%20non-diabetic:%20a%20case%20report&amp;author=S.%20Slade&amp;author=J.%20Ashurst&amp;volume=4&amp;issue=2&amp;publication_year=2020&amp;pages=259-262&amp;pmid=32426688&amp;doi=10.5811/cpcem.2020.2.44736&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<cite>
Sohal A., Casanova L., Kowdley K. V. (2024). A rare case of tirzepatide-induced hepatotoxicity. ACG Case Rep. J.
11 (10), e01484. 10.14309/crj.0000000000001484

</cite> [<a href="https://doi.org/10.14309/crj.0000000000001484" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11452087/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39372916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACG%20Case%20Rep.%20J.&amp;title=A%20rare%20case%20of%20tirzepatide-induced%20hepatotoxicity&amp;author=A.%20Sohal&amp;author=L.%20Casanova&amp;author=K.%20V.%20Kowdley&amp;volume=11&amp;issue=10&amp;publication_year=2024&amp;pages=e01484&amp;pmid=39372916&amp;doi=10.14309/crj.0000000000001484&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<cite>
Syed Y. Y. (2022). Tirzepatide: first approval. Drugs
82 (11), 1213–1220. 10.1007/s40265-022-01746-8

</cite> [<a href="https://doi.org/10.1007/s40265-022-01746-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35830001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Tirzepatide:%20first%20approval&amp;author=Y.%20Y.%20Syed&amp;volume=82&amp;issue=11&amp;publication_year=2022&amp;pages=1213-1220&amp;pmid=35830001&amp;doi=10.1007/s40265-022-01746-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<cite>
Terrington I., Thomas K., Stone H., Coad J., Khakoo S. (2024). Idiosyncratic acute liver failure induced by tirzepatide. J. Gastrointestin Liver Dis.
33 (4), 574–575. 10.15403/jgld-5967

</cite> [<a href="https://doi.org/10.15403/jgld-5967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39733320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Gastrointestin%20Liver%20Dis.&amp;title=Idiosyncratic%20acute%20liver%20failure%20induced%20by%20tirzepatide&amp;author=I.%20Terrington&amp;author=K.%20Thomas&amp;author=H.%20Stone&amp;author=J.%20Coad&amp;author=S.%20Khakoo&amp;volume=33&amp;issue=4&amp;publication_year=2024&amp;pages=574-575&amp;pmid=39733320&amp;doi=10.15403/jgld-5967&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62">
<cite>
Tucker J. M., Ritchie J. (2024). The tirzepatide drop: beware of slimmer's paralysis. J. Investig. Med. High. Impact Case Rep.
12, 23247096241264635. 10.1177/23247096241264635
</cite> [<a href="https://doi.org/10.1177/23247096241264635" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11273815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39051436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Investig.%20Med.%20High.%20Impact%20Case%20Rep.&amp;title=The%20tirzepatide%20drop:%20beware%20of%20slimmer's%20paralysis&amp;author=J.%20M.%20Tucker&amp;author=J.%20Ritchie&amp;volume=12&amp;publication_year=2024&amp;pages=23247096241264635&amp;pmid=39051436&amp;doi=10.1177/23247096241264635&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63">
<cite>
U.S. Food and Drug Administration. (2023). Ozempic (Semaglutide). Safety-related labeling changes approved by FDA Center for Drug Evaluation and Research (CDER). Available online at: <a href="https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/index.cfm?event=searchdetail.%20page&amp;DrugNameID=2183%20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/index.cfm?event=searchdetail.%20page&amp;DrugNameID=2183%20</a>. [Accessed March 10, 2025].
</cite> [<a href="https://scholar.google.com/scholar_lookup?U.S.%20Food%20and%20Drug%20Administration.%20(2023).%20Ozempic%20(Semaglutide).%20Safety-related%20labeling%20changes%20approved%20by%20FDA%20Center%20for%20Drug%20Evaluation%20and%20Research%20(CDER).%20Available%20online%20at:%20https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/index.cfm?event=searchdetail.%20page&amp;DrugNameID=2183%20.%20%5BAccessed%20March%2010,%202025%5D." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<cite>
U.S. Food and Drug Administration. (2024). FDA Approves First Medication for Obstructive Sleep Apnea. Available online at: <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea</a> [Accessed March 10, 2025].
</cite> [<a href="https://scholar.google.com/scholar_lookup?U.S.%20Food%20and%20Drug%20Administration.%20(2024).%20FDA%20Approves%20First%20Medication%20for%20Obstructive%20Sleep%20Apnea.%20Available%20online%20at:%20https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea%20%5BAccessed%20March%2010,%202025%5D." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64">
<cite>
Weber M., Siddarthan I., Mack P. F. (2023). Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss. Br. J. Anaesth.
131 (2), e37–e39. 10.1016/j.bja.2023.05.005

</cite> [<a href="https://doi.org/10.1016/j.bja.2023.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37302962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Anaesth.&amp;title=Clinically%20significant%20emesis%20in%20a%20patient%20taking%20a%20long-acting%20GLP-1%20receptor%20agonist%20for%20weight%20loss&amp;author=M.%20Weber&amp;author=I.%20Siddarthan&amp;author=P.%20F.%20Mack&amp;volume=131&amp;issue=2&amp;publication_year=2023&amp;pages=e37-e39&amp;pmid=37302962&amp;doi=10.1016/j.bja.2023.05.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65">
<cite>
Weyns F. J., Beckers F., Vanormelingen L., Vandersteen M., Niville E. (2007). Foot drop as a complication of weight loss after bariatric surgery: is it preventable?
Obes. Surg.
17 (9), 1209–1212. 10.1007/s11695-007-9203-2

</cite> [<a href="https://doi.org/10.1007/s11695-007-9203-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18074496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Obes.%20Surg.&amp;title=Foot%20drop%20as%20a%20complication%20of%20weight%20loss%20after%20bariatric%20surgery:%20is%20it%20preventable?&amp;author=F.%20J.%20Weyns&amp;author=F.%20Beckers&amp;author=L.%20Vanormelingen&amp;author=M.%20Vandersteen&amp;author=E.%20Niville&amp;volume=17&amp;issue=9&amp;publication_year=2007&amp;pages=1209-1212&amp;pmid=18074496&amp;doi=10.1007/s11695-007-9203-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66">
<cite>
Yang Z., Yu M., Mei M., Chen C., Lv Y., Xiang L., et al.  (2022). The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system. Nutr. Metab. Cardiovasc Dis.
32 (2), 504–510. 10.1016/j.numecd.2021.10.003

</cite> [<a href="https://doi.org/10.1016/j.numecd.2021.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34895802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutr.%20Metab.%20Cardiovasc%20Dis.&amp;title=The%20association%20between%20GLP-1%20receptor%20agonist%20and%20diabetic%20ketoacidosis%20in%20the%20FDA%20adverse%20event%20reporting%20system&amp;author=Z.%20Yang&amp;author=M.%20Yu&amp;author=M.%20Mei&amp;author=C.%20Chen&amp;author=Y.%20Lv&amp;volume=32&amp;issue=2&amp;publication_year=2022&amp;pages=504-510&amp;pmid=34895802&amp;doi=10.1016/j.numecd.2021.10.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67">
<cite>
Yin D. G., Ding L. L., Zhou H. R., Qiu M., Duan X. Y. (2021). Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials. Endocr. J.
68 (6), 739–742. 10.1507/endocrj.EJ21-0129

</cite> [<a href="https://doi.org/10.1507/endocrj.EJ21-0129" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34024887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocr.%20J.&amp;title=Comprehensive%20analysis%20of%20the%20safety%20of%20semaglutide%20in%20type%202%20diabetes:%20a%20meta-analysis%20of%20the%20SUSTAIN%20and%20PIONEER%20trials&amp;author=D.%20G.%20Yin&amp;author=L.%20L.%20Ding&amp;author=H.%20R.%20Zhou&amp;author=M.%20Qiu&amp;author=X.%20Y.%20Duan&amp;volume=68&amp;issue=6&amp;publication_year=2021&amp;pages=739-742&amp;pmid=34024887&amp;doi=10.1507/endocrj.EJ21-0129&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12259682/bin/Table1.docx" data-ga-action="click_feat_suppl" class="usa-link">Table1.docx</a><sup> (69.3KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The original contributions presented in the study are included in the article/<a href="#s13" class="usa-link">Supplementary Material</a>, further inquiries can be directed to the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Pharmacology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fphar.2025.1608657"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fphar-16-1608657.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (875.7 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12259682/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12259682/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12259682%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12259682/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12259682/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12259682/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40667509/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12259682/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40667509/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12259682/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12259682/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="je5a6ty0NmFRbFc6bOxsGIRUasZq7yXMOYcWROaKP4NG1iEGfcENp3xH9BzCk0d9">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
    

    </body>
</html>
